Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension

Henny JM Beckers, Jan SAG Schouten, Carroll AB WebersUniversity Eye Clinic, Maastricht, The NetherlandsAbstract: Brinzolamide 1%/timolol 0.5% is a new fixed-combination for the treatment of open-angle glaucoma or ocular hypertension. Brinzolamide/timolol has a favorable safety profile, with an incid...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Henny JM Beckers, Jan SAG Schouten, Carroll AB Webers
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/2fdc04c24a554665b28e6ef0fd5cc3bf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2fdc04c24a554665b28e6ef0fd5cc3bf
record_format	dspace
spelling	oai:doaj.org-article:2fdc04c24a554665b28e6ef0fd5cc3bf2021-12-02T07:52:06ZRole of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension1177-54671177-5483https://doaj.org/article/2fdc04c24a554665b28e6ef0fd5cc3bf2009-10-01T00:00:00Zhttp://www.dovepress.com/role-of-fixed-combination-brinzolamide-1timolol-05-in-the-treatment-of-a3655https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Henny JM Beckers, Jan SAG Schouten, Carroll AB WebersUniversity Eye Clinic, Maastricht, The NetherlandsAbstract: Brinzolamide 1%/timolol 0.5% is a new fixed-combination for the treatment of open-angle glaucoma or ocular hypertension. Brinzolamide/timolol has a favorable safety profile, with an incidence of ocular burning and stinging &lt;5%. Published data show that brinzolamide 1%/timolol 0.5% and dorzolamide 2%/timolol 0.5% have similar efficacies for lowering intraocular pressure (IOP). There is some evidence that brinzolamide/timolol may be more comfortable. Although patients receiving brinzolamide/timolol may experience more blurred vision on instillation, some data show a preference for brinzolamide/timolol over dorzolamide/timolol. Although available data to assess the role of brinzolamide/timolol in daily clinical practice are still limited, these first results suggest the agent to be a reasonable alternative for patients who do not reach target IOP with monotherapy. Henny JM BeckersJan SAG SchoutenCarroll AB WebersDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2009, Iss default, Pp 593-599 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Henny JM Beckers Jan SAG Schouten Carroll AB Webers Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
description	Henny JM Beckers, Jan SAG Schouten, Carroll AB WebersUniversity Eye Clinic, Maastricht, The NetherlandsAbstract: Brinzolamide 1%/timolol 0.5% is a new fixed-combination for the treatment of open-angle glaucoma or ocular hypertension. Brinzolamide/timolol has a favorable safety profile, with an incidence of ocular burning and stinging &lt;5%. Published data show that brinzolamide 1%/timolol 0.5% and dorzolamide 2%/timolol 0.5% have similar efficacies for lowering intraocular pressure (IOP). There is some evidence that brinzolamide/timolol may be more comfortable. Although patients receiving brinzolamide/timolol may experience more blurred vision on instillation, some data show a preference for brinzolamide/timolol over dorzolamide/timolol. Although available data to assess the role of brinzolamide/timolol in daily clinical practice are still limited, these first results suggest the agent to be a reasonable alternative for patients who do not reach target IOP with monotherapy.
format	article
author	Henny JM Beckers Jan SAG Schouten Carroll AB Webers
author_facet	Henny JM Beckers Jan SAG Schouten Carroll AB Webers
author_sort	Henny JM Beckers
title	Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
title_short	Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
title_full	Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
title_fullStr	Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
title_full_unstemmed	Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
title_sort	role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/2fdc04c24a554665b28e6ef0fd5cc3bf
work_keys_str_mv	AT hennyjmbeckers roleoffixedcombinationbrinzolamide1timolol05inthetreatmentofelevatedintraocularpressureinopenangleglaucomaandocularhypertension AT jansagschouten roleoffixedcombinationbrinzolamide1timolol05inthetreatmentofelevatedintraocularpressureinopenangleglaucomaandocularhypertension AT carrollabwebers roleoffixedcombinationbrinzolamide1timolol05inthetreatmentofelevatedintraocularpressureinopenangleglaucomaandocularhypertension
_version_	1718399147834343424

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension

Ejemplares similares